Fiscal Year (FY) 2014 Funding Opportunity, 68857-68858 [2013-27334]

Download as PDF Federal Register / Vol. 78, No. 221 / Friday, November 15, 2013 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: November 8, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2013–27349 Filed 11–14–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting emcdonald on DSK67QTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group; Acquired Immunodeficiency Syndrome Research Review Committee. Date: December 11, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Vasundhara Varthakavi, Ph.D., Scientific Review Officer, Scientific Review Program, NIH/NIAID/DEA/ARRB, 6700 B Rockledge Drive, Room 3256, Bethesda, MD 20892, 301–451–1740, varthakaviv@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 8, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27351 Filed 11–14–13; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 16:58 Nov 14, 2013 Jkt 232001 Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Urologic and Genitourinary Physiology and Pathology, October 25, 2013, 08:00 a.m. to October 25, 2013, 05:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on October 01, 2013, 78 FR 190 Pgs. 60296–60297. The meeting will start on December 6, 2013 at 8:00 a.m. and end on December 6, 2013 at 5:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: November 12, 2013. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27357 Filed 11–14–13; 8:45 am] BILLING CODE 4140–01–P 68857 October 21, 2013, 12:00 p.m. to October 21, 2013, 01:00 p.m., Hotel Palomar, 2121 P Street NW., Washington, DC 20037 which was published in the Federal Register on September 26, 2013, 78 FR 59362. The meeting will be held at the National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892. The meeting will be held on December 18, 2013 at 3:00 p.m. and end December 18, 2013 at 4:00 p.m. The meeting is closed to the public. Dated: November 8, 2013. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27355 Filed 11–14–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2014 Funding Opportunity Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award a single source grant to the Community Anti-Drug Coalitions of America (CADCA). AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Cancellation of Meeting Notice is hereby given of the cancellation of the Behavioral Medicine, Interventions and Outcomes Study Section, October 03, 2013, 8:00 a.m. to October 04, 2013, 5:00 p.m., The Allerton Hotel, 701 North Michigan Avenue, Chicago, IL 60611 which was published in the Federal Register on September 9, 2013, 78 FR 55087. The meeting is cancelled due to the reassignment of applications. Dated: November 8, 2013. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27354 Filed 11–14–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Synthetic and Biological Chemistry A, PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) intends to award $459,505 (total costs) for up to five years to CADCA for the National Substance Abuse Leadership Forum Cooperative Agreement. Under this initiative, CADCA will provide training and technical assistance to a large number of community leaders across the country who are committed to behavioral health (i.e., prevention, recovery, resilience, and wellness); and address current issues related to the prevention and treatment of substance abuse, and/or mental disorders across the nation. Conference and training activities supported through this cooperative agreement include SAMHSA’s Prevention Day, the Community AntiDrug Coalitions of America’s (CADCA) National Leadership Forum, and CADCA’s Mid-Year Training Institute. These conferences serve as a portal for knowledge dissemination and state-ofthe-art information transfer; and assist community leaders in developing effective local programs, practices, and policies that support national substance abuse prevention goals, outcomes and efforts, such as National Alcohol and SUMMARY: E:\FR\FM\15NON1.SGM 15NON1 emcdonald on DSK67QTVN1PROD with NOTICES 68858 Federal Register / Vol. 78, No. 221 / Friday, November 15, 2013 / Notices Drug Addiction Recovery Month, National Substance Abuse Prevention Month, and underage drinking prevention. The CADCA Conference initiative directly supports SAMHSA’s mission to reduce the impact of substance abuse and mental illness on America’s communities. This is not a formal request for applications. Assistance will be provided only to CADCA based on the receipt of a satisfactory application that is approved by an independent review group. Funding Opportunity Title: SP–14– 001. Catalog of Federal Domestic Assistance (CFDA) Number: 93.243. Authority: Section 516 of the Public Health Services Act, as amended. Funds for a portion of this initiative are also authorized under Sections 509, 516 and 520A of the Public Health Service Act, as amended. Justification: Eligibility for this award is limited to CADCA. The purpose of this cooperative agreement is to provide training and technical assistance for thousands of members of community coalitions dedicated to preventing substance abuse through a national leadership conference. CADCA is the only national organization that has special expertise and unique broad, national-level experience in working with community anti-drug coalitions. For more than 18 years, coalitions and coalition leadership have turned to CADCA to obtain the assistance they need to implement, operate, and sustain effective local community anti-drug strategies. The CADCA will take advantage of the resources of multiple agencies located throughout the federal, state and local governments, philanthropies, and universities to bring the best available knowledge, information, and technology to local community anti-drug coalitions working to prevent and reduce drug use among the youth of America. CADCA is the only identified organization with the required experience and national reach to over 5,000 identified anti-drug coalitions across the country. CADCA has long been recognized in communities as well as states throughout the nation as the national voice for the advocacy and technical support of anti-drug coalitions. As such, it is uniquely qualified and positioned to carry out the requirements of this announcement. Contact: Cathy Friedman, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Room 8–1097, Rockville, MD 20857; VerDate Mar<15>2010 16:58 Nov 14, 2013 Jkt 232001 telephone: (240) 276–2316; email: cathy.friedman@samhsa.hhs.gov. Cathy J. Friedman, SAMHSA Public Health Analyst. [FR Doc. 2013–27334 Filed 11–14–13; 8:45 am] DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5681–N–44] Federal Property Suitable as Facilities To Assist the Homeless Office of the Assistant Secretary for Community Planning and Development, HUD. AGENCY: Notice. This Notice identifies unutilized, underutilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless. SUMMARY: FOR FURTHER INFORMATION CONTACT: Juanita Perry, Department of Housing and Urban Development, 451 Seventh Street SW., Room 7262, Washington, DC 20410; telephone (202) 402–3970; TTY number for the hearing- and speechimpaired (202) 708–2565, (these telephone numbers are not toll-free), or call the toll-free Title V information line at 800–927–7588. In accordance with the December 12, 1988 court order in National Coalition for the Homeless v. Veterans Administration, No. 88–2503–OG (D.D.C.), HUD publishes a Notice, on a weekly basis, identifying unutilized, underutilized, excess and surplus Federal buildings and real property that HUD has reviewed for suitability for use to assist the homeless. Today’s Notice is for the purpose of announcing that no additional properties have been determined suitable or unsuitable this week. SUPPLEMENTARY INFORMATION: Dated: November 7, 2013. Mark R. Johnston, Deputy Assistant Secretary for Special Needs. [FR Doc. 2013–27125 Filed 11–14–13; 8:45 am] BILLING CODE 4210–67–P PO 00000 Fish and Wildlife Service [FWS–R8–R–2012–N115; 81683–1265–0000– S3] Seal Beach National Wildlife Refuge, Orange County, CA; Final Comprehensive Conservation Plan and Finding of No Significant Impact BILLING CODE 4162–20–P ACTION: DEPARTMENT OF THE INTERIOR Fish and Wildlife Service, Interior. ACTION: Notice of availability. AGENCY: We, the U.S. Fish and Wildlife Service (Service), announce the availability of our final Comprehensive Conservation Plan (CCP) and finding of no significant impact (FONSI) for the Seal Beach National Wildlife Refuge (Refuge). In the CCP, we describe how we will manage the Refuge for the next 15 years. DATES: The CCP and FONSI are available now. The FONSI was signed on September 30, 2011. The Final CCP was signed on May 18, 2012 and implementation of the CCP is underway. ADDRESSES: You may view or obtain copies of the Final CCP and FONSI/EA by any of the following methods. You may request a hard copy or CD–ROM. Agency Web site: Download a copy of the document(s) at https://www.fws.gov/ refuge/Seal_Beach/what_we_do/ planning.html. Email: Victoria_Touchstone@fws.gov. Include ‘‘Seal Beach CCP’’ in the subject line of the message. Fax: Attn: Victoria Touchstone, (619) 476–9150, extension 103. Mail: Victoria Touchstone, U.S. Fish and Wildlife Service, San Diego NWR Complex, P.O. Box 2358, Chula Vista, CA 91912. In-Person Viewing or Pickup: Copies of the Final CCP and FONSI may also be viewed at the San Diego National Wildlife Refuge Complex, 1080 Gunpowder Point Drive, Chula Vista, CA 91910 (call 619–476–9150, extension 103, for directions and hours). Local Library: The full document is also available at the Seal Beach/Mary Wilson Library, 707 Electric Avenue, Seal Beach, CA 90740. FOR FURTHER INFORMATION CONTACT: Victoria Touchstone, Refuge Planner, at 619–476–9150, extension 103 (see ADDRESSES), or Kirk Gilligan, Refuge Manager, at 562–598–1024. SUPPLEMENTARY INFORMATION: SUMMARY: Background Legislation authorizing the establishment of the Seal Beach National Wildlife Refuge was signed by Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 78, Number 221 (Friday, November 15, 2013)]
[Notices]
[Pages 68857-68858]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27334]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Fiscal Year (FY) 2014 Funding Opportunity

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice of intent to award a single source grant to the 
Community Anti-Drug Coalitions of America (CADCA).

-----------------------------------------------------------------------

SUMMARY: This notice is to inform the public that the Substance Abuse 
and Mental Health Services Administration (SAMHSA) intends to award 
$459,505 (total costs) for up to five years to CADCA for the National 
Substance Abuse Leadership Forum Cooperative Agreement. Under this 
initiative, CADCA will provide training and technical assistance to a 
large number of community leaders across the country who are committed 
to behavioral health (i.e., prevention, recovery, resilience, and 
wellness); and address current issues related to the prevention and 
treatment of substance abuse, and/or mental disorders across the 
nation.
    Conference and training activities supported through this 
cooperative agreement include SAMHSA's Prevention Day, the Community 
Anti-Drug Coalitions of America's (CADCA) National Leadership Forum, 
and CADCA's Mid-Year Training Institute. These conferences serve as a 
portal for knowledge dissemination and state-of-the-art information 
transfer; and assist community leaders in developing effective local 
programs, practices, and policies that support national substance abuse 
prevention goals, outcomes and efforts, such as National Alcohol and

[[Page 68858]]

Drug Addiction Recovery Month, National Substance Abuse Prevention 
Month, and underage drinking prevention. The CADCA Conference 
initiative directly supports SAMHSA's mission to reduce the impact of 
substance abuse and mental illness on America's communities.
    This is not a formal request for applications. Assistance will be 
provided only to CADCA based on the receipt of a satisfactory 
application that is approved by an independent review group.
    Funding Opportunity Title: SP-14-001.
    Catalog of Federal Domestic Assistance (CFDA) Number: 93.243.
    Authority: Section 516 of the Public Health Services Act, as 
amended. Funds for a portion of this initiative are also authorized 
under Sections 509, 516 and 520A of the Public Health Service Act, as 
amended.
    Justification: Eligibility for this award is limited to CADCA. The 
purpose of this cooperative agreement is to provide training and 
technical assistance for thousands of members of community coalitions 
dedicated to preventing substance abuse through a national leadership 
conference. CADCA is the only national organization that has special 
expertise and unique broad, national-level experience in working with 
community anti-drug coalitions. For more than 18 years, coalitions and 
coalition leadership have turned to CADCA to obtain the assistance they 
need to implement, operate, and sustain effective local community anti-
drug strategies. The CADCA will take advantage of the resources of 
multiple agencies located throughout the federal, state and local 
governments, philanthropies, and universities to bring the best 
available knowledge, information, and technology to local community 
anti-drug coalitions working to prevent and reduce drug use among the 
youth of America. CADCA is the only identified organization with the 
required experience and national reach to over 5,000 identified anti-
drug coalitions across the country. CADCA has long been recognized in 
communities as well as states throughout the nation as the national 
voice for the advocacy and technical support of anti-drug coalitions. 
As such, it is uniquely qualified and positioned to carry out the 
requirements of this announcement.
    Contact: Cathy Friedman, Substance Abuse and Mental Health Services 
Administration, 1 Choke Cherry Road, Room 8-1097, Rockville, MD 20857; 
telephone: (240) 276-2316; email: cathy.friedman@samhsa.hhs.gov.

Cathy J. Friedman,
SAMHSA Public Health Analyst.
[FR Doc. 2013-27334 Filed 11-14-13; 8:45 am]
BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.